Company ProfilePremium

Asit C. Mehta Financial Services Ltd.

Company Profile Analysis

Ticker: 530723.BO

ESOMAR 23 Corporate BadgeISO Certifications Badge
Asit C. Mehta Financial Services Ltd. - Company showcase

Year Founded & Workforce

1984

Asit C. Mehta Financial Services Ltd. logo

Asit C. Mehta Financial Services Ltd. Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Asit C. Mehta Financial Services Ltd. Overview

FieldDetailSource
Legal nameAsit C. Mehta Financial Services LimitedBSE filings; Letter of Offer (LoF) Dec-2023
Former namesNorthern India Leasing Limited (1984); Nucleus Securities Limited (from 8 Jul 1993); Nucleus Netsoft and GIS (India) Limited (from 31 May 2006); current name from 11 Sep 2008LoF Dec-2023
Founding / incorporationIncorporated 25 January 1984 as a public limited company. Certificate issued by the RoC, Delhi & HaryanaLoF Dec-2023
Group heritageAsit C. Mehta began equity broking in 1983 as a proprietorship. The broking subsidiary was reconstituted as a company in December 1993CRISIL rationale Aug-2024 / Nov-2025
JurisdictionIndia. Companies Act, 1956/2013. Registered office moved to Maharashtra (RoC Mumbai) effective 26 Jul 1995LoF Dec-2023
CINL65900MH1984PLC091326BSE filings
Registered office / HQPantomath Nucleus House, Saki Vihar Road, Andheri (East), Mumbai 400072, MaharashtraBSE filings 2024–2026
Exchange / tickerBSE: 530723 / ASITCFIN. Equity listed on BSE since August 1998 (per Simply Wall St). Not listed on NSEBSE; Simply Wall St
ISININE041B01014. No CUSIP: the shares carry no US listing or ADRLoF Dec-2023
Face value₹10 per shareLoF Dec-2023
Shares outstanding82,46,012 equity shares (post-Rights Issue, January 2024)Board's Report FY2024; Shareholding pattern Mar-2026
Fiscal year end31 MarchAnnual Reports
Statutory auditorM/s Manek & Associates, Chartered Accountants (FRN 0126679W). Appointed 18 Nov 2023 to fill a casual vacancy after M/s MSKA & Associates resigned; re-appointed at the 40th AGM (30 Sep 2024)Board's Reports FY2024, FY2025
Internal auditorM/s MAKK & Associates (FRN 117246W), FY2025Board's Report FY2025
Secretarial auditorM/s Hemanshu Kapadia & Associates, Practising Company SecretariesBoard's Report FY2025
Registrar & Transfer AgentMUFG Intime India Pvt. Ltd. (formerly Link Intime India), Vikhroli (West), MumbaiVogue/Dion Global company page
EmployeesNot publicly disclosed (see note below)Board's Report FY2025; LoF Dec-2023
Market capitalisation≈ ₹86–89 Cr. ₹88.8 Cr at ₹108 (3 Sep 2026, Screener); ≈ ₹86 Cr at ₹104 (9 Sep 2026, Anand Rathi).Screener; Anand Rathi
52-week range₹164 high / ₹92 lowScreener (Sep-2026)
Websitewww.acmfsl.com. Subsidiary's retail platform: Investmentz (investmentz.com)BSE filings
Parent / controlling shareholderCliqtrade Stock Brokers Pvt. Ltd. holds 52.20% (Pantomath Group, promoted by Mahavir and Madhu Lunawat). ACMFSL became a subsidiary of Cliqtrade after the January 2024 Rights IssueBoard's Report FY2024; Shareholding Mar-2026
Material subsidiaryAsit C. Mehta Investment Interrmediates Ltd. (ACMIIL), 94.58%Board's Report FY2024; CRISIL Nov-2025
Other subsidiaryEdgytal Fintech Investment Services Pvt. Ltd., 90.38% at 31 Mar 2024Board's Report FY2024

Note on employee count. A consolidated headcount is not disclosed in the sources reviewed. The FY2025 Board's Report states that the standalone headcount is below the threshold that requires an Internal Complaints Committee under the POSH Act; that threshold is 10 employees. The Letter of Offer discloses group attrition of 35% in FY2021, 28% in FY2022 and 18% (annualised) in FY2023, but not absolute headcount. A three-year headcount trend is therefore not publicly disclosed.

ACMFSL is a micro-cap Indian holding company. Its economic value lies almost entirely in its 94.58% subsidiary, ACMIIL, a four-decade-old Mumbai full-service stockbroker, depository participant, research house and portfolio manager built by Asit C. Mehta and Deena Mehta. At the standalone level, ACMFSL owns and leases its Andheri office building ("Pantomath Nucleus House") to group companies, earns small corporate-advisory fees, and holds the fintech subsidiary Edgytal.

Between 2022 and 2024, control passed from the Mehta family to the Pantomath Group of Mahavir and Madhu Lunawat. This happened through an open offer, share purchases and a ₹45.27 Cr rights issue. Since then the business has been repositioned as the broking, wealth and distribution arm of a mid-market investment-banking ecosystem.

The company is sub-scale, carries roughly ₹106 Cr of consolidated borrowings, and has reported consolidated losses in each of FY2023–FY2026. Its investment case rests on Pantomath synergies, deleveraging and promoter capital support.


What the company does

ACMFSL operates on two layers.

Holding-company (standalone) layer. The listed company's own operations are small. In the FY2025 Board's Report, management states three things:

  • the company has let out its office premises on a lease / leave-and-license basis to group companies;

  • it earned ₹115.36 lakh from investment activities in FY2025;

  • its standalone gross earnings rose to ₹667.56 lakh, from ₹547.09 lakh in FY2024.

The standalone entity also provides advisory and consultancy services on fund mobilisation, capital restructuring and corporate financial strategy to SME clients. Fee income from this line was ₹28.25 lakh in FY2023 and ₹25.92 lakh in FY2024 (Board's Reports FY2023, FY2024).

Following the NCLT-sanctioned merger of the wholly-owned Nucleus IT Enabled Services Ltd. (order dated 20 January 2023; appointed date 31 March 2021), the standalone company also carries a residual IT-enabled services line. This line recorded ₹10.44 lakh of revenue in Q2 FY2026 (standalone results, Q2 FY2026, per ScanX).

Operating-subsidiary layer. Asit C. Mehta Investment Interrmediates Ltd. (ACMIIL) generates the large majority of consolidated revenue. The FY2025 Board's Report describes it as:

  • a material subsidiary providing broking, research and analysis, and distribution of PMS, mutual funds and other financial products;

  • a corporate member of BSE and NSE;

  • a depository participant with CDSL.

ACMIIL holds SEBI registrations for stock broking, depository participation, portfolio management and research analysis (LoF Dec-2023). CRISIL's November 2025 rationale lists its activities as retail and institutional broking, research, portfolio management services, distribution and margin trade funding.

Business model and revenue model

Revenue streamNatureEntityApproximate significanceSource
Brokerage (cash, F&O, currency, commodity)Transaction fees on client turnover; full-service plus a discount planACMIILDominant. Stock broking and allied services were ₹26.69 Cr in 9M FY2024 against consolidated revenue from operations of ₹31.52 Cr (≈85%)Equitybulls / company release, Feb-2024
Depository (DP) feesAccount maintenance and transaction charges; CDSL DPACMIIL—LoF Dec-2023
Interest income (margin trade funding, client financing, deposits)Spread incomeACMIIL—CRISIL Nov-2025
PMS management / performance feesAUM-linked; discretionary PMS (ACE strategies)ACMIILPMS AUM ≈ ₹145–180 Cr in 2026PMS Bazaar Jun-2026; Business Today
Distribution commissions (MF, IPO, bonds, FDs, NPS, insurance, AIF)Trail and upfront commissionsACMIILMF distribution business sold May 2026 for ₹6.59 CrScanX, May/Aug 2026
Institutional equities and researchBrokerage on institutional flows; researchACMIILScaling after Pantomath link (20 institutions onboarded per FY2023 Board's Report)Board's Report FY2023
Arbitrage / proprietary (delta-hedged)Trading incomeACMIIL—CRISIL Aug-2024
Fintech platform servicesB2B wealthtech platform, IT servicesEdgytal₹283.20 lakh (FY2024); ₹3.66 lakh (FY2025)Board's Reports FY2024, FY2025
Rental / leave-and-licenseLease of Pantomath Nucleus House to group companiesACMFSL standaloneCore of standalone revenueBoard's Report FY2025
Corporate advisoryFund-mobilisation / restructuring advisory to SMEsACMFSL standalone₹25.92 lakh (FY2024)Board's Report FY2024

ACMFSL's consolidated revenue is overwhelmingly service / transaction-based. There is no product sales, subscription or licensing revenue of any significance.

Value-chain position, customers and end-markets

In the Indian capital-markets value chain, ACMIIL sits at the intermediary / distribution layer. It stands between investors and market infrastructure institutions (BSE, NSE, MCX, CDSL) and between investors and product manufacturers (AMCs, issuers, AIF managers).

ACMFSL's customer types are:

  1. retail investors, including HNIs, served through the Investmentz app/web/CTCL platforms and an associate network across roughly 218 cities (LoF Dec-2023);

  2. NRIs, through dedicated distribution products;

  3. institutional clients for equity research and execution;

  4. SME corporates for advisory;

  5. B2B intermediaries (sub-brokers, MF agents, insurance and postal agents) recruited for the B2B network (Board's Report FY2023).

All end-markets are domestic Indian. The FY2025 Board's Report records no foreign-exchange earnings or outgo.

The company's own description

In the Rights Issue Letter of Offer (Dec-2023), the company describes itself as a technology-led integrated financial services organisation. It says it operates through ACMIIL and Edgytal across stock broking, portfolio management, wealth management and fintech, and that its purpose is to provide appropriate financial services to every Indian entity (paraphrased).

The FY2025 Board's Report describes ACMIIL as having helped over 2 lakh customers build wealth over 42 years, and highlights two flagship products: iBasket and PMS.

Independent characterisation

ACMFSL is best understood as a thinly capitalised listed shell around a legacy full-service retail broker, now controlled by an investment-banking group seeking a broking and distribution platform. Four features define it.

  1. Scale. ACMIIL's market share of retail equity broking turnover was about 0.001% in FY2025. Its share of exchange-level active clients was 0.04% as of March 2025, with an active base of 23,000–24,000 clients (CRISIL, Nov-2025).

  2. Cost structure. ACMIIL's net cost-to-income ratio was 100% in FY2025 and 101% in H1 FY2026 (CRISIL, Nov-2025). This reflects heavy investment in people and technology that revenue has not yet absorbed.

  3. Balance sheet. Consolidated borrowings were ₹106.37 Cr at March 2026, against consolidated net worth of roughly ₹23 Cr (Screener). This makes interest cost the single largest drag on earnings.

  4. Strategic dependency. Revenue growth since FY2024 has been tied to deal flow and capital from the Pantomath Group. CRISIL explicitly notes business flowing in from Pantomath's IPO-solutions and AIF businesses, and the promoters' commitment to provide capital as required.

Strategy

Stated strategic themes (paraphrased from company documents)

  1. Integrated, technology-led financial services. Provide.

  2. Wealth management build-out. Distribute high-end products (PMS, AIFs, MFs) to affluent clients (Board's Report FY2023).

  3. NRI distribution. Pan-India senior hiring for NRI products (Board's Report FY2023).

  4. B2B network expansion. Recruit sub-brokers, insurance, MF and postal agents through webinars (Board's Report FY2023).

  5. Inorganic consolidation. Acquire smaller broking firms that want to exit because of compliance cost (Board's Report FY2023; Investor Presentation Jun-2022, citing industry consolidation pressure).

  6. Institutional equities research. Build research coverage to raise institutional rankings and flows (Board's Report FY2023). The Q3 FY2024 release attributes institutional broad-basing to Pantomath's investment-banking strength.

  7. Retail micro-investing. "Chhota Nivesh", iBaskets, NPS, SGBs, G-secs, corporate FDs and T-bills, all on one app (Board's Report FY2023).

  8. Pantomath ecosystem synergy. At the time of the Cliqtrade acquisition, Pantomath described the deal as part of diversification across investment banking, wealth and fund management, institutional outreach and broking. This included merging its PMS with ACM (Private Banker International, Feb-2023).

Initiatives announced in the last 24 months (Oct 2024 – Oct 2026)

DateInitiativeDetail / targetsStatusSource
FY2025Capital infusion into ACMIIL₹10 Cr through optionally convertible cumulative redeemable preference sharesCompleted; ACMIIL gearing 3.1x (Mar 2025) and 2.3x (Sep 2025)CRISIL Nov-2025
13 Aug 2024 (approved in FY2025)Variation of Rights Issue objects₹250 lakh redirected from the Omniscience Capital Advisors acquisition to business expansion, IP development, working capital and promotionApproved by Board; shareholder approval soughtBoard's Report FY2024
11 Dec 2024Governance alignment of the material subsidiaryListed-company IDs placed on the ACMIIL board after fresh broker registrationCompletedBSE filing
31 Jul 2025₹50 Cr Rights IssuePrice, ratio and record date delegated to a Rights Issue CommitteePending. No letter of offer or record date located as of Oct 2026BSE filing 31 Jul 2025
14 May 2026Divestment of the MF distribution businessSlump sale to Wealth Company Pvt. Ltd. for ₹659 lakh, to strengthen ACMIIL's financial position, reduce losses and focus on core operationsCompleted (gain booked in Q1 FY2027)BSE / Sharekhan; ScanX; Groww
2 Sep 2026Related-party transaction frameworkAGM resolutions for RPT limits of up to ₹55.5 Cr and ₹50 CrPlaced before the 42nd AGM (24 Sep 2026)Screener / BSE
OngoingDiscount broking planCompete with discount brokers for new clientsLaunched (date not disclosed)CRISIL Aug-2024

ESG and sustainability commitments: none announced. BRSR and CSR are not applicable (Board's Report FY2025).

Cost programmes: no formal programme or target is announced. FY2026 operating expenses fell ₹13 Cr year on year (Screener).

Medium-term targets and guidance

The company does not publish financial guidance or medium-term targets. There have been no earnings calls since the 2022 investor presentations. The only externally articulated benchmarks are CRISIL's rating-sensitivity thresholds for ACMIIL:

Upgrade triggers: a cost-to-income ratio sustainably below 70% and a higher client broking market share.

Downgrade triggers: cost-to-income above 100% for two further quarters, or gearing above 5x on a steady-state basis.

Products & Services

Broking and execution (ACMIIL)

OfferingDescription / capabilitiesTarget customerLaunch / statusPricing modelSource
Equity cash broking (BSE / NSE)Delivery and intraday executionRetail, HNI, NRISince 1983/1993Turnover-linked brokerage (full-service); discount plan also offeredLoF Dec-2023; CRISIL Nov-2025
Equity derivatives (F&O)Futures and options on exchangesActive traders, HNIsOngoingBrokerage plus pass-through chargesLoF Dec-2023
Currency and interest-rate derivativesExchange-traded currency and IRDTraders, hedgersOngoingBrokerageLoF Dec-2023
Commodity derivativesMCX registration referencedTradersOngoingBrokerageLoF Dec-2023 (risk factor references MCX)
Discount broking planLow-tariff plan to compete with discount brokersPrice-sensitive retailLaunched before Aug-2024 (exact date not disclosed)Flat / low fees (rates not disclosed)CRISIL Aug-2024
Margin trade fundingLeveraged funding of client positionsActive retail / HNIOngoingInterest incomeLoF Dec-2023; CRISIL Nov-2025
IPO / OFS / Offer-to-BuyExchange-platform primary and secondary offeringsRetailOngoingDistribution / brokerageLoF Dec-2023
Institutional equitiesResearch-backed execution for institutionsDomestic institutions20 institutions onboarded per FY2023 Board's ReportInstitutional brokerageBoard's Report FY2023
Arbitrage tradingDelta-hedged arbitrage bookProprietaryOngoingTrading gainsCRISIL Aug-2024

Platforms

PlatformDescriptionStatusSource
Investmentz (app, web, CTCL)Single digital platform for trading, investment products, IPOs, bonds, NPS, SGBs and moreFlagship retail platformLoF Dec-2023; Board's Report FY2023
EasyTradez.comTrade-execution platformOperational (per Simply Wall St description)Simply Wall St
"Chhota Nivesh"Platform for retail investors investing small sumsLaunched around FY2023Board's Report FY2023
Edgytal fintech platformB2B wealthtech platform supporting distribution of marketable securitiesRevenue collapsed to ₹3.66 lakh in FY2025Board's Reports FY2024, FY2025

Advisory, portfolio management and research

StrategyCategoryLaunch dateAUMBenchmark3-year annualised return vs benchmarkSource
Asit C Mehta – ACE MulticapFlexi / total-cap value strategy23 Aug 2018₹142.07 CrBSE 500 TRI26.28% vs 13.47%Groww PMS page (2026)
Asit C Mehta – ACE Multi-asset PortfolioValue strategy with regular payouts; 95% equity at last disclosure4 Oct 2018₹17.97 CrNSE Multi Asset Index 225.15% vs 11.44%Groww PMS page
Asit C Mehta – ACE Ten Trillion OpportunitiesMid/small-cap value (76% small-cap)29 Dec 2017₹9.59 CrBSE 500 TRI28.66%Groww PMS page
Asit C Mehta – ACE Blue-chipLarge-cap value29 Dec 2017₹4.40 CrBSE 500 TRI18.88%Groww PMS page

iBasket is a professionally curated stock basket built with a "scientific investing" approach. Per the FY2025 Board's Report, its stated aims are capital safety, value identification, thematic growth and under-researched opportunities. It targets retail and HNI investors. The launch year and pricing are not disclosed.

PMS (discretionary) — ACE strategies. Fund manager: Prathmesh Agrawal, CA, previously VP (Investments) at ENAM Asset Management; Deepak Makwana is also listed as a portfolio manager. Common terms across strategies: minimum investment ₹50 lakh (SEBI minimum) and an exit load of 2%.

PMS performance figures are as presented by third-party aggregators and are not SEBI-verified. Groww's "date as of" for the 3-year returns was not displayed.

Total PMS AUM. PMS Bazaar reports ₹146.04 Cr as of 30 June 2026; Sharescart reports ₹145 Cr as of 1 June 2026 (rank #228); Business Today reports ₹180.02 Cr (date not stated). The discrepancy likely reflects different reference dates.

Other advisory and research services:

Research Analyst services: (SEBI RA registration): equity research for retail and institutional clients (LoF Dec-2023).

Wealth management services: distribution of high-end products including PMS, AIFs and MFs, launched around FY2023 (Board's Report FY2023).

IPO reviews: published on third-party platforms; for example, a review of Ardee Industries' August 2026 IPO (IPOPremium).

Distribution and savings products

OfferingStatusSource
Mutual fund distributionSold through a slump sale to Wealth Company Pvt. Ltd. for ₹659 lakh, approved 14 May 2026BSE / Sharekhan; ScanX
Fixed income: company FDs, T-Bills, RBI bonds, G-SecsOffered onlineLoF Dec-2023; Board's Report FY2023
Sovereign Gold Bonds, digital goldOfferedLoF Dec-2023
National Pension System (NPS)Offered on InvestmentzBoard's Report FY2023
NRI distribution productsSenior staff recruited pan-IndiaBoard's Report FY2023
Insurance / postal agent network (B2B)Agents being registered through webinarsBoard's Report FY2023

Depository and custody

ACMIIL is a CDSL depository participant. It held about ₹4,000 Cr of client securities in depository and about ₹100 Cr in advisory services as of August 2023 (LoF Dec-2023). Pricing is standard DP fees and is not disclosed.

Standalone (ACMFSL) services

OfferingDetailSource
Infrastructure leasingLease / leave-and-license of Pantomath Nucleus House to group companiesBoard's Report FY2025
Corporate advisoryFund mobilisation, restructuring and corporate financial strategy for SMEsScreener key points citing AR FY2025; Board's Report FY2024
Investment activities₹115.36 lakh of revenue in FY2025Board's Report FY2025
IT-enabled services (legacy Nucleus ITES)BPO, data de-duping, digital consulting (SEO, SMO, paid media, web development), recruitment and training. ₹10.44 lakh of revenue in Q2 FY2026Simply Wall St; ScanX

Financial Narrative

Income statement (consolidated)

Sources: Screener consolidated P&L; Board's Reports FY2023–FY2025. FY2022 total income from the FY2023 Board's Report. FY2026 total income of ₹6,588.94 lakh and net loss of ₹160.11 lakh from ScanX (FY2026 audited results). EPS discrepancy: for FY2023 and FY2024 the company-reported EPS is computed on loss attributable to owners over weighted shares, while Screener's derivation differs. FY2026 EPS is per Screener; Kotak Neo reports Q4 FY2026 EPS of ₹1.39 versus Screener's ₹1.24.

Margins and growth

Revenue CAGR (FY2022–FY2026):

  • Screener sales: (61.23 / 41.37)^(1/4) − 1 ≈ 10.3%

  • Company total income: (65.89 / 41.54)^(1/4) − 1 ≈ 12.2%

  • Screener reports 3-year compounded sales growth of 22% and 5-year growth of 9%.

Quarterly trajectory (consolidated)

Source: Screener consolidated quarterly. Q1 FY2027 net profit is ₹485.13 lakh per ScanX. Univest reports ₹4.00 Cr and IndMoney ₹4.56 Cr for the same quarter; the differences likely reflect profit attributable to owners versus total, or pre/post-OCI measures. Q1 FY2027 "other income" in the Screener basis includes the gain on the MF-distribution slump sale. ScanX separately reports underlying other income falling to ₹41.23 lakh from ₹112.85 lakh.

Commentary. The income statement shows a business whose operating line has recovered but whose financing structure absorbs all of it.

FY2022: was the high-water mark. Strong retail participation produced ₹11.9 Cr of EBITDA, and a small profit survived ₹7.9 Cr of interest.

FY2023–FY2024: saw ACMIIL's costs rise sharply as the new promoters hired senior staff and invested in technology, wealth management, NRI distribution and institutional research (Board's Report FY2023; CRISIL Aug-2024). EBITDA collapsed to about ₹1.4–1.6 Cr while interest rose above ₹10 Cr, producing losses of ₹9–11 Cr.

FY2025: was the inflection. Total income grew 65% to ₹77.9 Cr, with Q4 FY2025 alone contributing ₹29.5 Cr of sales, presumably institutional and IPO-linked flows from the Pantomath ecosystem. EBITDA recovered to ₹9.4 Cr, but net income remained negative after ₹10 Cr of interest.

FY2026: revenue fell 15% as market activity cooled and SEBI's F&O framework bit. However, EBITDA rose to ₹10.4 Cr, helped by ₹4.66 Cr of other income and cost reductions (operating expenses fell ₹13 Cr), and the net loss narrowed to ₹1.6 Cr.

Q1 FY2027: profit of about ₹4.85 Cr is non-recurring, driven by the MF-distribution sale. Underlying operating profit was slightly negative.

The quarterly pattern alternates between profitable and loss-making quarters. This is consistent with lumpy institutional, IPO and advisory revenues layered on a fixed cost and interest base of roughly ₹13–14 Cr per quarter.

Balance sheet (consolidated)

Sources: Screener consolidated balance sheet. Book value per share for FY2022–FY2025 per Bajaj Broking; FY2026 computed as ₹22.98 Cr / 82.46 lakh shares (Screener shows ₹27.9). FY2023 negative equity excludes the subsequent rights issue.

Items not available on a five-year basis:

Cash & equivalents: are not separately disclosed in the five-year aggregator data. Simply Wall St reports ₹32.5 Cr of cash, ₹98.6 Cr of debt and ₹24.3 Cr of equity, apparently as of 30 September 2025. Broker cash typically includes client and margin bank balances, so this figure overstates free cash.

Debt split: - The Letter of Offer (FY2023) shows unsecured borrowings of ₹5,707.38 lakh (31 Mar 2023), ₹4,745.32 lakh (31 Mar 2022) and ₹3,511.57 lakh (31 Mar 2021). The FY2023 balance comprised 4% unsecured redeemable NCDs (₹2,006.56 lakh), director loans (₹1,072.56 lakh), inter-corporate deposits at 11–12% (₹2,612.32 lakh) and other items. All of these were repayable on demand.

  • Secured debt includes ACMIIL's bank overdrafts (₹31.3 Cr sanctioned from SBI and Bank of India, per CRISIL) and the 10.5% secured NCDs (₹777 lakh per the FY2024 Board's Report; the same text cites "717" debentures of ₹1 lakh each, an internal inconsistency).

  • A precise short-term / long-term split for FY2026 is not publicly available in the sources reviewed. Simply Wall St notes that short-term liabilities (≈ ₹110 Cr) exceeded short-term assets (₹83 Cr).

Working capital: Screener working-capital days: FY2022 93.5; FY2023 −52.3; FY2024 −40.4; FY2025 14.8; FY2026 −418.1. These are not meaningful for a broker because client payables and receivables dominate.

Cash flow (consolidated)

Sources: Screener consolidated cash flows. Capex is derived as CFO minus FCF. Company-reported FY2023 consolidated CFO was ₹-568.74 lakh and FY2022 ₹-208.82 lakh (LoF), which differ slightly from Screener.

Commentary. Operating cash flow was negative in FY2022–FY2025 and only marginally positive in FY2026, with no internally generated free cash flow over five years. MarketsMojo similarly flags four consecutive years of negative operating cash flow up to FY2025.

The deficit was funded externally:

  • promoter and director loans and inter-corporate deposits (FY2021–FY2023);

  • the ₹45.27 Cr rights issue (FY2024), of which ₹27.45 Cr was a conversion of Cliqtrade's loan and ₹10.30 Cr repaid promoter and ICD loans;

  • fresh borrowings in FY2025.

FY2026 marks the first year of net debt repayment (−₹21.7 Cr financing outflow), partly funded by ₹11.2 Cr of investing inflows from investment liquidation; the investment book fell from ₹17.2 Cr to ₹6.6 Cr.

Key ratios

Sources: computed from Screener data. FY2023 ROE and D/E are not meaningful because consolidated equity was negative; they are shown as 0 for charting only. Screener reports FY2026 ROE of −6.84% on average equity and a 3-year average ROE of −23.6%.

Ratios not computable or not disclosed:

Net debt / EBITDA: not computable reliably without year-end free cash. On gross debt, debt/EBITDA was 10.2x in FY2026 and 12.6x in FY2025.

Current ratio: not disclosed on a five-year basis. Per Simply Wall St, short-term assets of ₹83.0 Cr against short-term liabilities of ₹110 Cr imply about 0.75x, apparently at September 2025.

ROIC: not disclosed. ROCE serves as the proxy.

Interpretation. Leverage is the defining financial characteristic. Interest of ₹9.5–11.1 Cr a year has exceeded or roughly equalled EBITDA in every year since FY2023.

At the subsidiary level, CRISIL reports ACMIIL gearing of 5.8x (FY2024), 3.1x (FY2025) and 2.3x (September 2025). This improvement came after ACMFSL infused ₹10 Cr of preference capital, funded by the rights issue.

At the holding-company level, the standalone entity carries significant legacy debt (standalone finance cost was ₹669.48 lakh in FY2025) against modest rental income. The planned ₹50 Cr rights issue would be decisive for deleveraging, but no record date or letter of offer had been located as of October 2026.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Group Entities

EntityRelationshipStake held by ACMFSLActivitiesSource

Cliqtrade Stock Brokers Pvt. Ltd.

Holding company of ACMFSL (Pantomath Group)

n/a (holds 52.20% of ACMFSL)

Investment vehicle of Mahavir and Madhu Lunawat

Shareholding Mar-2026; CRISIL Nov-2025

Asit C. Mehta Financial Services Ltd.

Listed company (BSE)

—

Property leasing, SME advisory, investments, residual ITES

Board's Report FY2025

Asit C. Mehta Investment Interrmediates Ltd. (ACMIIL)

Material subsidiary

94.58% (remainder held by Deena Mehta)

Broking, DP, PMS, research, distribution, MTF, institutional equities

Board's Report FY2024; CRISIL

Edgytal Fintech Investment Services Pvt. Ltd.

Subsidiary

90.38% (31 Mar 2024), up from 73% (Jun 2022)

Fintech platform for distribution of marketable securities

Board's Reports FY2024, FY2025

Nucleus IT Enabled Services Ltd.

Former wholly-owned subsidiary; merged into ACMFSL

Merged (appointed date 31 Mar 2021)

BPO / data de-duplication and digital consulting

Board's Report FY2023

Results by Segment

Metric (INR Lakh)FY2022FY2023FY2024FY2025

ACMIIL income from operations (INR Lakh)

3,569.262,750.994,051.54—

ACMIIL total income per CRISIL (INR Lakh)

3,9673,1644,4937,610

Edgytal income from operations (INR Lakh)

18.15120.77283.203.66

ACMFSL standalone revenue from operations (INR Lakh)

—335.22461.77416.05

ACMFSL standalone total income (INR Lakh)

420.44530.00547.09667.56

Consolidated revenue from operations (INR Lakh)

—2,920.674,239.887,264.08

Consolidated total income (INR Lakh)

4,154.083,383.244,709.037,786.24

Results by Segment — ACMIIL PAT

Metric (INR Lakh)FY2022FY2023FY2024FY2025

ACMIIL PAT (INR Lakh)

626.09-255.43-533.7615

Edgytal PAT (INR Lakh)

-23.46-129.23-28.45-1.92

ACMFSL standalone PAT (INR Lakh)

-438.70-559.99-502.28-281.73

Consolidated PAT (INR Lakh)

146.33-931.25-1,111.33-276.30

Income Statement and Per-Share Data

Metric (INR Cr)FY2022FY2023FY2024FY2025FY2026

Sales / revenue (Screener basis, INR Cr)

41.3733.7446.2677.0861.23

Total income, company-reported (INR Cr)

41.5433.8347.0977.8665.89

Operating expenses (INR Cr)

30.3532.4445.4568.4955.45

Operating profit before other income (INR Cr)

11.021.300.818.595.78

Other income (INR Cr)

0.870.090.830.784.66

EBITDA (INR Cr)

11.891.391.649.3710.44

Depreciation (INR Cr)

1.671.561.622.092.43

Operating income / EBIT (INR Cr)

10.22-0.170.027.288.01

Finance cost (INR Cr)

7.9310.1711.1110.029.53

Profit before tax (INR Cr)

2.29-10.34-11.09-2.74-1.52

Net profit (INR Cr)

1.46-9.31-11.12-2.76-1.60

EPS basic, Screener (INR)

1.32-10.88-13.10-3.35-2.01

EPS basic & diluted, company-reported (INR)

3.02-19.06-19.51-3.35-2.01

Dividend per share (INR)

00000

Margin Analysis (%)

Metric (%)FY2022FY2023FY2024FY2025FY2026

Operating margin before other income, Screener OPM (%)

26.643.851.7511.149.44

EBITDA margin on total income (%)

28.64.13.512.015.8

EBIT margin on total income (%)

24.6-0.50.09.412.2

Net margin on total income (%)

3.5-27.5-23.6-3.5-2.4

Total income growth YoY (%)

—-18.639.265.3-15.4

Income Statement

Metric (INR Cr)Q2FY2025Q3FY2025Q4FY2025Q1FY2026Q2FY2026Q3FY2026Q4FY2026Q1FY2027

Sales (INR Cr)

14.8115.3429.5311.2421.6713.5814.7311.24

Other income (INR Cr)

1.551.321.121.541.271.040.807.74

Operating profit (INR Cr)

1.06-0.884.50-0.953.34-0.033.44-0.02

Interest (INR Cr)

2.562.502.802.442.472.352.282.04

Profit before tax (INR Cr)

-0.45-2.572.26-2.451.54-1.941.334.97

Net profit (INR Cr)

-0.33-2.532.01-2.411.57-1.921.154.85

Balance Sheet and Per-Share Data

Metric (INR Cr)FY2022FY2023FY2024FY2025FY2026

Equity share capital (INR Cr)

4.854.958.258.258.25

Reserves (INR Cr)

1.01-8.3920.9317.2914.73

Shareholders' equity (INR Cr)

5.86-3.4429.1825.5422.98

Borrowings, total (INR Cr)

106.65116.2892.88118.02106.37

Other liabilities (INR Cr)

57.8346.4570.0154.4760.41

Total assets (INR Cr)

170.34159.29192.07198.03189.76

Fixed assets, net (INR Cr)

56.8155.4757.3458.2958.48

Capital work-in-progress (INR Cr)

10.0011.2012.2210.288.19

Investments (INR Cr)

7.3710.349.2017.166.60

Other assets incl. cash, receivables, client balances (INR Cr)

96.1682.28113.31112.30116.49

Book value per share (INR)

12.09-6.9335.3830.9727.87

Cash Flow

Metric (INR Cr)FY2022FY2023FY2024FY2025FY2026

Cash from operating activities (INR Cr)

-3.34-5.69-0.42-6.370.39

Capital expenditure, derived (INR Cr)

11.261.474.581.090.64

Free cash flow (INR Cr)

-14.60-7.16-5.00-7.46-0.25

Cash from investing activities (INR Cr)

-22.773.59-12.08-0.4411.21

Cash from financing activities (INR Cr)

28.331.0510.8114.72-21.65

Net cash flow (INR Cr)

2.22-1.05-1.697.90-10.05

Dividends paid (INR Cr)

00000

Share buybacks (INR Cr)

00000

Returns & Leverage Ratios (%) and Financial Ratios (x)

MetricFY2022FY2023FY2024FY2025FY2026

ROE, year-end equity (%)

24.90-38.1-10.8-7.0

ROA (%)

0.86-5.84-5.79-1.39-0.84

ROCE, Screener (%)

8.14-0.150.025.415.79

Debt / equity (x)

18.203.184.624.63

Interest coverage, EBITDA / interest (x)

1.500.140.150.941.10

Asset turnover, sales / total assets (x)

0.240.210.240.390.32

Debtor days / cash conversion cycle (days)

48.0868.4887.7439.2671.95

Results by Region

Region (INR Cr)FY2024FY2025FY2026

India, total income (INR Cr)

47.0977.8665.89

Outside India, total income (INR Cr)

000

Valuation Snapshot

MetricValueDateSource

Last verified price

₹104.00

9 Sep 2026

Anand Rathi

Prior reference

₹108 (−2.97% on day)

3 Sep 2026

Screener

Market capitalisation

≈ ₹86 Cr (₹104) to ₹88.8 Cr (₹108)

Sep 2026

Computed; Screener

52-week high / low

₹164 / ₹92

2026

Screener; Upstox

Liquidity

Thin (e.g. 631 shares traded on 18 Jun 2026)

Jun 2026

MarketsMojo

CAGR by Horizon

HorizonCAGR (%)

1-year

-17

3-year

-2

5-year

8

10-year

26

Valuation Multiples

MultipleACMFSLBasis / commentSource

P/E (TTM)

≈ 15.7x on ₹5.65 Cr TTM PAT at ₹88.8 Cr market cap

TTM includes the one-off gain on the MF business sale; P/E is negative ex-gain

Computed from Screener

P/B

≈ 3.9x (₹108 / ₹27.9 book)

Range of 4.1–4.4x reported by ICICIdirect and Anand Rathi in Jun–Sep 2026

Screener; ICICIdirect; Anand Rathi

EV / Sales

≈ 3.2x gross of cash: (₹88.8 Cr + ₹106.4 Cr borrowings) / ₹61.2 Cr TTM sales

Overstated because cash is excluded

Computed

EV / EBITDA

≈ 18–19x gross of cash: ₹195 Cr / ₹10.4 Cr FY2026 EBITDA

Overstated because cash is excluded

Computed

Key Events

EventDateSharesPriceAmountSource

Rights Issue

Dec 2023 – Jan 2024

32,93,452

₹137.45

₹4,526.85 lakh

LoF; Board's Report FY2024

Proposed Rights Issue

Approved 31 Jul 2025

TBD

TBD

Up to ₹5,000 lakh

BSE filing

Margin Analysis (%) — Promoter holding

MetricFY2022FY2023FY2024FY2025FY2026

Promoter holding (%)

74.5977.5374.9974.9974.99

Public holding (%)

24.9222.4725.0225.0225.02

Number of shareholders

2,9621,9972,1882,0832,050

Issuer Details

IssuerAgencyRatingOutlookDateFacilities

ACMFSL (listed parent)

—

Not rated by Moody's, S&P, Fitch or Indian agencies (no rating found)

———

ACMIIL (subsidiary)

CRISIL Ratings

BBB- (long term) / A3 (short term)

Stable

Reaffirmed 24 Nov 2025 (previously Aug 2024, May 2023, Mar 2022, Jan 2022)

₹40 Cr bank facilities: SBI OD ₹30 Cr; Bank of India OD ₹1.3 Cr; proposed LT ₹1.7 Cr; proposed ST ₹7 Cr

Analyst Conclusions

Management guidance and consensus

Management provides no quantitative guidance and there is no consensus. Qualitatively, the May 2026 disclosures frame the MF-business sale as a step to improve net worth, reduce losses and focus on core operations. The pending ₹50 Cr rights issue signals intent to recapitalise.

CRISIL's expectation is that ACMIIL's market position will improve with Pantomath synergies. It treats profitable scale-up as a monitorable rather than a base case.

Bull case

  1. Deleveraging re-rating. A fully subscribed ₹50 Cr rights issue, likely anchored by Cliqtrade given its record of converting ₹27.45 Cr of loans in 2024, could cut gross borrowings from ₹106 Cr to about ₹56 Cr. That would save roughly ₹5 Cr of annual interest at 10.5–12% and make the FY2026 EBITDA of ₹10.4 Cr translate into a sustainable profit.

  2. Ecosystem revenue leverage. FY2025 showed that Pantomath-linked flows can lift revenue 65% in a year (Q4 FY2025 sales of ₹29.5 Cr). A recovering SME/mid-market IPO cycle could repeat this on a leaner cost base, since FY2026 operating expenses were ₹13 Cr lower.

  3. Hidden asset value. The owned Andheri HQ (about ₹58 Cr of fixed assets at book), a PMS franchise with ₹145–180 Cr AUM and strong aggregator-reported returns, and residual investments provide asset backing. The ₹6.59 Cr MF-business sale shows a willingness to crystallise value.

Bear case

  1. Structural unprofitability. Four consecutive annual losses (FY2023–FY2026), negative free cash flow in each of the last five years and ACMIIL cost-to-income at or above 100% suggest the franchise does not earn its cost of capital. The Q1 FY2027 profit is one-off.

  2. Leverage and liquidity fragility. With D/E at 4.6x, interest coverage around 1x and demand-repayable ICDs and unsecured loans, any market downturn or lender recall could force further dilutive raises. The September 2026 NCD maturity adds near-term pressure.

  3. Minority-shareholder governance risk. The holding is at the 75% promoter cap, RPT limits exceed net worth, a divested business may have gone to an affiliate, there is a history of SEBI and exchange penalties and frequent KMP and auditor turnover. At a P/B of about 4x, the stock prices in a turnaround that has not materialised.

Catalysts and monitorables (next 12 months)

Catalyst / monitorableWhy it mattersTiming
Rights issue terms (price, ratio, record date) and promoter subscriptionDetermines dilution and deleveragingPending since Jul 2025
Repayment or refinancing of the 10.5% NCDs (₹7.77 Cr)Near-term liquidity test~Sep 2026 (verify)
42nd AGM outcomes, especially RPT approvals and counterpartiesGovernance read-throughHeld 24 Sep 2026 (verify)
Q2 FY2027 results (ex-gain profitability)Tests the core earnings run-rate after the MF saleNov 2026
CRISIL surveillance of ACMIIL (cost-to-income < 100%; gearing < 5x)Downgrade triggers~Nov 2026
SEBI F&O and MII rule effects on retail volumesRevenue sensitivityOngoing
PMS AUM trajectoryQuality-revenue growthQuarterly
Pantomath IPO / AIF pipeline flowing to ACMIILLumpy revenue upsideOngoing

Concluding analyst verdict

Asit C. Mehta Financial Services is not, economically, the four-decade broking brand its name evokes. It is a leveraged micro-cap holding company whose value depends on whether a new controlling shareholder can turn a sub-scale, cost-heavy full-service broker into a profitable distribution arm.

Since Pantomath took control, the evidence is mixed but directionally improving:

  • revenue more than doubled between FY2023 and FY2025;

  • the subsidiary's gearing more than halved;

  • consolidated losses narrowed from ₹11.1 Cr in FY2024 to ₹1.6 Cr in FY2026;

  • the group has begun pruning non-core lines.

Yet the core problem is unresolved. Roughly ₹10 Cr of annual interest on about ₹106 Cr of borrowings consumes essentially all of an EBITDA that is itself volatile and partly dependent on related-group flows. The company has not produced free cash flow in five years, has paid no dividend since 2010, and carries no institutional ownership or analyst coverage.

At about ₹86–89 Cr of market value and roughly four times book, the market is already capitalising a successful recapitalisation and synergy story. The single most important variable is the long-pending ₹50 Cr rights issue: its pricing, the extent of Cliqtrade's participation, and whether the proceeds retire debt rather than fund related-party activity. Its execution would convert a balance-sheet-constrained story into one tested on operating merit.

Until then, the investment profile is that of a special situation with high governance and liquidity risk. Minority investors are largely along for the controlling group's ride and face dilution, related-party and illiquidity risks that the current valuation does not appear to discount. Prudent monitoring should centre on:

  • ex-gain quarterly profitability from Q2 FY2027;

  • ACMIIL's cost-to-income ratio relative to CRISIL's 100% downgrade trigger;

  • debt maturities;

  • the terms and counterparties of approved related-party transactions.

Verdict: speculative turnaround, contingent on recapitalisation. Fundamentals do not yet support the prevailing price-to-book multiple.


  • Consolidated employee headcount and its three-year trend.

  • FY2025 and FY2026 Ind AS 108 segment revenue and results (primary PDFs inaccessible).

  • Detailed KMP remuneration breakdown (salary, bonus, stock).

  • Year-end cash and equivalents, and the short-/long-term debt split for FY2022–FY2026.

  • Goodwill and intangibles.

  • Industry market-size estimates from primary sources.

  • Outcomes of the 42nd AGM (24 Sep 2026), NCD repayment status (Sep 2026) and the October 2026 share price.

  • Related-party status of Wealth Company Pvt. Ltd. (buyer of the MF distribution business).

  • Contents of the SEBI adjudication order of 29 Sep 2015 against ACMFSL.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Board of Directors

NameDesignationSinceBackgroundCompensation (latest available)Source

Ambareesh Bhaskar Baliga

Chairman; Non-Executive Independent Director; Chair of NRC

Director since 26 Dec 2022. Chair since 2024/25 (signed the Q3 FY2026 results as Chairman)

—

Sitting fees ≈ ₹2.5 lakh

Board's Reports FY2023, FY2025; ScanX Jan-2026; Simply Wall St

Krishan Kumar Jalan (DIN 01767702)

Non-Executive Independent Director; Chair of Audit Committee

29 Jun 2024 (5-year term); on ACMIIL board from 11 Dec 2024

——

Board's Report FY2025; BSE 12 Dec 2024

Suresh Kumar Jain (DIN 05103064)

Non-Executive Independent Director

23 May 2024 (5-year term); on ACMIIL board from 11 Dec 2024

——

Board's Report FY2025

Yagnesh P. Parikh (DIN 09762673)

Non-Executive Independent Director

9 Nov 2023 (5-year term)

——

Board's Report FY2024

Deena Asit Mehta (DIN 00168992)

Non-Executive Non-Independent Director (promoter); Chair of SRC

Board tenure ≈ 34.7 years per Simply Wall St. Also MD of ACMIIL

CA (associate member, ICAI); postgraduate in management (finance). Former BSE President; former CDSL director; India Board of CISI (per CRISIL and public profiles)

Sitting fees ≈ ₹1.5 lakh; holds 4.13%

CRISIL; Wikipedia; Simply Wall St; Shareholding Mar-2026

Madhu Lunawat (DIN 06670573)

Non-Executive Non-Independent Director (promoter group, Pantomath)

26 Dec 2022

Pantomath co-founder; earlier at Infosys and ASREC (India); CFO of Edelweiss ARC; launched The Wealth Company Mutual Fund

—

CRISIL Nov-2025; Board's Report FY2023

“—” = not publicly disclosed.

Directors' Remuneration

CommitteeMembersSource

Audit

K.K. Jalan (Chair), A. Baliga, M. Lunawat, S.K. Jain

Board's Report FY2025

Nomination & Remuneration

A. Baliga (Chair), K.K. Jalan, D. Mehta, Y. Parikh

Board's Report FY2025

Stakeholders' Relationship

D. Mehta (Chair), K.K. Jalan, A. Baliga, M. Lunawat, S.K. Jain

Board's Report FY2025

Executive Leadership Team

NameRoleTenureAgeCompensationSource

Binoy Kantilal Dharod

Chief Financial Officer (from 5 Aug 2022); Manager under the Companies Act (from 8 Feb 2024, 5-year term)

≈ 4 years as CFO

38 (per Simply Wall St, 2025)

≈ ₹15 lakh total (per Simply Wall St; FY2025 basis)

Board's Reports FY2024, FY2025; Simply Wall St

Ankit Kumar Jain

Company Secretary & Compliance Officer

From 13 Jan 2026

——

ScanX / BSE Jan-2026

“—” = not publicly disclosed.

Board & Management Changes

DateChangeContextSource

26 Dec 2022

Madhu Lunawat and Ambareesh Baliga appointed

Pantomath entry after the open offer

Board's Report FY2023

22 Aug 2023

Manohar Lal Vij ceases

Pre-rights-issue board reshuffle

Board's Report FY2024

9 Nov 2023

R.K. Murthy and Kirit Vora cease; Yagnesh Parikh appointed

Vora sold 2,48,350 ACMIIL shares to ACMFSL (rights-issue object)

Board's Report FY2024; LoF

18 Nov 2023

Auditor change (MSKA resigns; Manek appointed)

Second auditor change in about 17 months

Board's Reports FY2023, FY2024

8 Feb 2024

Binoy Dharod appointed Manager

Replaced Pankaj Parmar

Board's Report FY2024

May–Jul 2024

S.K. Jain and K.K. Jalan join; P. Sanyal retires

Board refresh

Board's Report FY2025

29 Oct 2024

Asit C. Mehta resigns as Chairman and Director

Completes founder hand-over to Pantomath

Board's Report FY2025

27 Nov 2025 / 13 Jan 2026

CS changes (Pandey out, Jain in)

Third CS in about three years

BSE; ScanX

Major Shareholders

HolderCategoryShares%

Cliqtrade Stock Brokers Pvt. Ltd.

Promoter (corporate)

43,04,282

52.20

Asit Chimanlal Mehta

Promoter

14,43,693

17.51

Deena Asit Mehta

Promoter

3,40,783

4.13

Asit Chimanlal Mehta HUF

Promoter

77,0000.93

Jayesh T. Desai HUF

Promoter

11,8540.14

Others in promoter group (Gopa J. Desai, Rupa A. Shah)

Promoter

≈ 5,660 (derived)

≈ 0.07

Total promoter & promoter group (7 holders)

—

61,83,272

74.98

Public (2,092 holders)

Public

20,62,740

25.02

Competitive Landscape

Competitors by Segment

SegmentNamed competitorsRelative positioning vs ACMIIL

Discount / digital retail broking

Zerodha (unlisted), Groww (Billionbrains Garage Ventures), Angel One, Upstox, Dhan

Dominant scale; ACMIIL's 0.04% active-client share (Mar 2025) is tiny by comparison (CRISIL)

Bank-led broking

ICICI Securities, HDFC Securities, Kotak Securities, SBI Securities, Axis Securities

Captive bank distribution; CRISIL flags the regulatory shift favouring larger digital and bank-based brokers

Large listed full-service / wealth

Motilal Oswal Financial Services, IIFL Capital Services, Anand Rathi Share & Stock Brokers, Nuvama Wealth, Geojit Financial Services

Broad product shelves and research depth

Small / mid listed brokers (closest peers)

Share India Securities, Monarch Networth Capital, SMC Global Securities, Arihant Capital Markets, Inventure Growth & Securities, Choice International

Comparable heritage, but most are profitable and larger

Traditional Mumbai full-service (unlisted)

Prabhudas Lilladher, Nirmal Bang, Sharekhan (now Mirae Asset Sharekhan)

Same client archetype (HNI, relationship-led)

Institutional equities / ECM-linked

DAM Capital Advisors, Equirus, Pantomath (sister group)

ACMIIL's institutional desk is nascent (20 institutions onboarded per FY2023)

PMS / boutique wealth

Omniscience Capital, ENAM-heritage boutiques, Marcellus, numerous small PMS

ACMIIL's PMS AUM of ₹145–180 Cr ranks around #228 among PMS providers (Sharescart)

Peer Comparison FY2026

MetricACMFSL (consolidated)DAM Capital AdvisorsShare India Securities

Q1 FY2027 total income

≈ ₹18.98 Cr (incl. one-off gain; Screener total income)

₹30.0 Cr (−2.9% YoY)

—

Q1 FY2027 PAT

₹4.85 Cr (one-off driven)

₹0.15 Cr (0.5% margin)

Company cites highest-ever quarterly net profit

Business mix

Retail broking, PMS, distribution

Merchant banking ₹9.5 Cr; institutional broking ₹16.3 Cr

Algo / tech-driven broking; average daily turnover ₹90 Bn

Net cash / leverage

Net debt (borrowings ₹106 Cr, Mar 2026)

Net cash ₹312 Cr (30 Jun 2026)

ROA 1.71% (Q1 FY2027)

Company Snapshot

$1.7M

Revenue

1984

Founded

Mumbai, India

Headquarters

SWOT Analysis

Strengths

  • Controlling-shareholder support. Cliqtrade (Pantomath) holds 52.20%. CRISIL states that the promoters are committed to providing capital support and have high financial flexibility; this was evidenced by Cliqtrade converting ₹27.45 Cr of loans into equity in the January 2024 rights issue (LoF; CRISIL Nov-2025).
  • Revenue scaling under the new owners. Consolidated total income grew from ₹33.8 Cr (FY2023) to ₹77.9 Cr (FY2025), +130% in two years (Board's Reports).
  • Improved subsidiary leverage. ACMIIL's gearing fell from 5.8x (Mar 2024) to 2.3x (Sep 2025) after the ₹10 Cr preference infusion (CRISIL).
  • PMS franchise. ACE Multicap AUM of ₹142 Cr with a three-year annualised return of 26.28% against 13.47% for the benchmark (Groww aggregator).
  • Owned real estate. About ₹58 Cr of fixed assets, mostly the Andheri HQ, generates rental income from group companies (Screener; Board's Report FY2025).
  • Clean audit opinions and a stable rating. Unmodified audit opinions for FY2024–FY2026, and CRISIL BBB-/Stable/A3 reaffirmed four times between 2022 and 2025 (Board's Reports; CRISIL).

Weaknesses

  • Persistent losses. Consolidated net losses in FY2023 (₹9.31 Cr), FY2024 (₹11.12 Cr), FY2025 (₹2.76 Cr) and FY2026 (₹1.60 Cr) (Screener).
  • Interest burden. Finance cost of ₹9.5–11.1 Cr a year exceeds or matches EBITDA; interest coverage was 0.94x in FY2025 and 1.10x in FY2026.
  • Cost inefficiency. ACMIIL's net cost-to-income was 113% (FY2024), 100% (FY2025) and 101% (H1 FY2026) (CRISIL).
  • No internal free cash flow. Free cash flow was negative in each of FY2022–FY2026 (Screener).
  • Negligible market share. 0.001% of turnover and 0.04% of active clients (CRISIL Nov-2025).
  • Thin equity. Consolidated net worth of about ₹23 Cr against borrowings of ₹106 Cr (D/E 4.6x, Mar 2026). Equity was negative at March 2023 (Screener).
  • Failed initiatives. Edgytal revenue collapsed from ₹283 lakh to ₹3.66 lakh (FY2025), and the Omniscience acquisition was abandoned (Board's Reports).

Opportunities

  • ₹50 Cr rights issue. If completed, it would more than double net worth and could retire roughly half of borrowings, saving an estimated ₹4–5 Cr of interest at the 10.5–12% funding costs disclosed. This is an analyst estimate (BSE filing Jul-2025; LoF ICD rates).
  • Pantomath IPO and AIF flows. CRISIL notes that revenue is already benefiting. The FY2025 Q4 sales spike to ₹29.5 Cr illustrates the upside from lumpy mandates.
  • Consolidation of sub-scale brokers. The company's stated strategy is to acquire firms exiting because of compliance costs (Board's Report FY2023).
  • HNI and NRI wealth. PMS, AIF and NRI distribution build-outs are in place (Board's Report FY2023).
  • Asset monetisation. The MF business was sold for ₹6.59 Cr in May 2026; further non-core sales are possible, for example Pentation Analytics (₹5.95 Cr investment at cost, FY2023).
  • Cost rationalisation. FY2026 operating expenses already fell by ₹13 Cr (Screener).

Threats

  • Regulatory compression of derivatives volumes. SEBI's F&O framework, the MII charge revision and STT increases (CRISIL Nov-2025).
  • Discount-broker pricing. CRISIL notes full-service brokers have been less competitive in client acquisition over the past 8–12 quarters.
  • Refinancing and liquidity. ₹21 Cr of repayments were due within a month of August 2025 against ₹14.4 Cr of undrawn OD lines (CRISIL Nov-2025). Unsecured loans are repayable on demand (LoF).
  • Regulatory enforcement. The SEBI ₹15 lakh penalty (Dec 2022) involved misuse of client funds and incorrect margin reporting. The LoF discloses 33 SEBI/exchange disciplinary actions against ACMIIL over five fiscal years.
  • Related-party concentration. AGM 2026 RPT limits of ₹55.5 Cr and ₹50 Cr, each larger than net worth (BSE AGM notice).
  • Key-person and transition risk. The founder exited the board in October 2024, and there has been frequent KMP turnover (three CSs since 2023; two auditor changes in 2022–23).

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
23 May 2025FY2025 audited results approved; consolidated loss narrows to ₹276.30 lakh on total income of ₹7,786.24 lakh Board's Report FY2025; Vogue/DionRevenue up 65%; the operating turnaround is visible
23 May 2025Declaration of unmodified audit opinion filed (after the prior-year XBRL lapse) Board's Report FY2025Compliance remediation
25 Jul 2025Board meeting notice: Q1 results plus consideration of a rights issue ScanXSignals capital raise
31 Jul 2025Q1 FY2026: consolidated loss of ₹240 lakh (vs ₹191.55 lakh); ₹50 Cr rights issue approved; Rights Issue Committee formed BSE filing; ScanXMajor dilution / deleveraging plan
31 Jul 2025FY2025 Board's Report signed (by Deena Mehta and Madhu Lunawat) Board's Report FY2025Discloses secretarial audit lapses
Aug 2025AGM notice: 41st AGM on 29 Sep 2025; Deena Mehta's re-appointment by rotation; five-year appointment of the secretarial auditor proposed Capital Market; Board's Report FY2025Routine governance
29 Sep 202541st AGM held Emkay/DionResolutions passed (scrutiniser's report filed 1 Oct 2025)
17 Oct 2025Sep-2025 shareholding: promoters 74.99%, public 25.02% Vogue/DionStable control
30 Oct 2025Board meeting notice for Q2 ScreenerRoutine
11 Nov 2025Q2 FY2026: consolidated profit of about ₹1.45–1.57 Cr; standalone loss of ₹67.59 lakh ScanX; Tickertape; ScreenerLumpy institutional revenue (sales ₹21.67 Cr)
24 Nov 2025CRISIL reaffirms ACMIIL at BBB-/Stable/A3; H1 FY2026 PAT ₹0.01 Cr; gearing 2.3x CRISIL Nov-2025Credit stable; liquidity tight (₹21 Cr of near-term repayments against ₹14.4 Cr of undrawn OD at Aug 2025)
27 Nov 2025CS Puspraj R. Pandey resigns Screener / BSEKMP turnover
23 Dec 2025Trading window closure for Q3 ScreenerRoutine
13 Jan 2026Ankit Kumar Jain appointed CS & Compliance Officer ScanXFills KMP vacancy within regulatory time
14 Jan 2026Regulation 74(5) compliance certificate ScreenerRoutine
17 Jan 2026Dec-2025 shareholding filed; unchanged Emkay/DionStable
31 Jan 2026Q3 FY2026: standalone revenue ₹118.93 lakh (vs ₹72.00 lakh); consolidated loss ₹191.85 lakh ScanXContinued losses in non-lumpy quarters
5–7 Feb 2026Share price around ₹130; P/B about 4.7x Angel OneValuation peak of the period
14 May 2026Sale of ACMIIL's MF distribution business to Wealth Company Pvt. Ltd. for ₹659 lakh BSE / Sharekhan; ScanXMonetises a non-core line; one-off gain
26 May 2026FY2026 audited results: consolidated loss ₹160.11 lakh; total income ₹6,588.94 lakh; unmodified opinion Screener; ScanXFourth consecutive annual loss, but narrowing
27–28 May 2026Q4 FY2026: sales ₹14.73 Cr (−50% YoY); PAT about ₹1.0–1.15 Cr MarketsMojo; Kotak NeoRevenue normalisation after the Q4 FY2025 spike
late May 2026Annual Secretarial Compliance Report (Reg. 24A) for FY2026 notes minor past lapses, overall compliant ScreenerGovernance hygiene improving
Jun 2026PMS AUM about ₹145–146 Cr; ACE Multicap the dominant strategy PMS Bazaar; SharescartWealth franchise intact post MF sale
7 Aug 2026Q1 FY2027: consolidated PAT ₹485.13 lakh (vs loss of ₹2.4 Cr); sales ₹11.24 Cr; gain on slump sale ScanX; Univest; ScreenerFirst large profit since FY2022; non-recurring
17 Aug 2026Shareholder intimation to update KYC and dematerialise physical shares Screener; GrowwRoutine
1–3 Sep 2026Newspaper notices for the 42nd AGM and e-voting ScreenerRoutine
2 Sep 2026Notice of 42nd AGM and FY2026 Annual Report; RPT limits of up to ₹55.5 Cr and ₹50 Cr sought Screener / BSELarge RPT approvals relative to a ₹23 Cr net worth; a governance monitorable
9 Sep 2026Share price ₹104; down about 24% over one year Anand RathiMarket scepticism despite the Q1 profit
24 Sep 202642nd AGM (scheduled) Screener / BSE–
~25 Sep 2026Scheduled maturity of the 10.5% secured NCDs allotted 25 Sep 2023 (36 months), ≈ ₹7.77 Cr Board's Report FY2024–

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

4 charts
Income Statement: Revenue & Gross Profit: Sales / revenue rose from INR 413.7 Mn in FY2022 to INR 612.3 Mn in FY2026.
Asit C. Mehta Financial Services Ltd. — Income Statement: Revenue & Gross Profit
Series (INR Mn)FY2022FY2023FY2024FY2025FY2026
Sales / revenue413.7337.4462.6770.8612.3

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.